|
WO2021011369A1
|
|
Methods of treatment using encapsulated cells
|
|
WO2020160457A1
|
|
Treatment of atopic dermatitis using mesenchymal stem cells and immune modulation
|
|
US2017183633A1
|
|
Methods using reprogrammed cells for regenerative, restorative, and rejuvenative therapies
|
|
US2017232276A1
|
|
Treatment of fibrosis using deep tissue heating and stem cell therapy
|
|
AU2015284180A1
|
|
Gonad-derived side population stem cells
|
|
US2014220551A1
|
|
Cryopreservation of cells and tissue for clinical application
|
|
WO2009140655A1
|
|
Methods for efficient viral reprogramming of somatic cells into stem cell-like pluripotent cells
|
|
EP2527426A1
|
|
Isolation, characterization and propagation of germline stem cells
|
|
WO2009032456A2
|
|
Non-viral delivery of transcription factors that reprogram human somatic cells into a stem cell-like state
|
|
WO2008076465A1
|
|
Microinjector chip
|
|
WO2007115216A1
|
|
Reprogramming of adult human testicular stem cells to pluripotent germ-line stem cells
|
|
WO2007076458A1
|
|
Microinjector chip
|
|
IL179927D0
|
|
Therapeutic reprogramming, hybrid stem cells and maturation
|
|
US2007020759A1
|
|
Therapeutic reprogramming of germ line stem cells
|
|
WO2007012009A1
|
|
Therapeutic reprogramming of germ line stem cells
|
|
WO2006084229A2
|
|
Use of nuclear material to therapeutically reprogram differentiated cells
|
|
AU2006210463A1
|
|
Use of nuclear material to therapeutically reprogram differentiated cells
|
|
US2006188491A1
|
|
Use of nuclear material to therapeutically reprogram differentiated cells
|
|
AU2005322873A1
|
|
Adipose-derived stem cells for tissue regeneration and wound healing
|
|
BRPI0511889A
|
|
therapeutic reprogramming, hybrid stem cells and maturation
|
